Showing results (1-10 of 173) with videos related to
Sort By:
Pageof 18
Current Opinion in Organ Transplantation|October 6, 2011
Targeting JAK3 in kidney transplantation: current status and future optionsDavid Wojciechowski, Flavio VincentiSeminars in Immunology|August 23, 2011
Challenges and opportunities in targeting the costimulation pathway in solid organ transplantationDavid Wojciechowski, Flavio VincentiCurrent Opinion in Organ Transplantation|October 9, 2010
How the development of new biological agents may help minimize immunosuppression in kidney transplantation: the impact of belataceptDavid Wojciechowski, Flavio VincentiExpert Opinion on Investigational Drugs|July 12, 2013
Tofacitinib in kidney transplantationDavid Wojciechowski, Flavio VincentiCurrent Opinion in Organ Transplantation|October 10, 2012
Belatacept in kidney transplantationDavid Wojciechowski, Flavio VincentiCurrent Opinion in Nephrology and Hypertension|August 13, 2016
Current status of costimulatory blockade in renal transplantationDavid Wojciechowski, Flavio VincentiAdvances in Chronic Kidney Disease|October 16, 2016
Costimulatory Blockade and Use of mTOR Inhibitors: Avoiding Injury Part 2David Wojciechowski, Flavio VincentiBiologics : Targets & Therapy|November 16, 2012
Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an updateDavid Wojciechowski, Flavio VincentiClinical Transplantation|February 13, 2017
Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipientsDavid Wojciechowski, Sindhu Chandran, Flavio VincentiClinical Transplantation|June 30, 2017
Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: A single-center clinical experienceDavid Wojciechowski, Sindhu Chandran, Joshua Y C Yang, et al.Pageof 18